Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase

Rita Benkö, Pál Pacher, Anne Vaslin, Márk Kollai, Csaba Szabo

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Oxidant-mediated activation of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) plays a role in the development of endothelial dysfunction and the pathogenesis of various cardiovascular diseases. The aim of the current study was to investigate whether activation of PARP contributes to the development of endothelial dysfunction in the apolipoprotein E (ApoE) deficient mice. We tested whether PARP inhibition prevents the development of endothelial dysfunction and whether it restores function in vessels with established endothelial dysfunction. ApoE deficient mice were kept on high-fat diet for 12 weeks with and without INO-1001 treatment. Chronic treatment with the PARP inhibitor INO-100 reduced the degree of the endothelial dysfunction (the ability of the vessel to relax to acetylcholine) in the thoracic aortae of ApoE deficient mice. In addition, in vitro incubation of vessels from ApoE deficient mice with established endothelial dysfunction with the PARP inhibitor acutely improved the ability of the rings to relax to acetylcholine. We conclude that the early atherosclerotic functional alterations that develop in the endothelium of the ApoE deficient mice are, at least in part, reversible, and are dependent on the activation of the nuclear enzyme PARP in the endothelial cells.

Original languageEnglish (US)
Pages (from-to)1255-1261
Number of pages7
JournalLife Sciences
Volume75
Issue number10
DOIs
StatePublished - Jul 23 2004
Externally publishedYes

Fingerprint

Poly(ADP-ribose) Polymerases
Apolipoproteins E
Restoration
Pharmacology
Enzymes
Enzyme Activation
Chemical activation
Acetylcholine
Endothelial cells
High Fat Diet
Nutrition
Thoracic Aorta
Oxidants
Endothelium
Cardiovascular Diseases
Endothelial Cells
Fats

Keywords

  • Atherosclerosis
  • DNA
  • Endothelium
  • Oxidative stress

ASJC Scopus subject areas

  • Pharmacology

Cite this

Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase. / Benkö, Rita; Pacher, Pál; Vaslin, Anne; Kollai, Márk; Szabo, Csaba.

In: Life Sciences, Vol. 75, No. 10, 23.07.2004, p. 1255-1261.

Research output: Contribution to journalArticle

@article{f0e1485ac41d48fd923f13ff2e2b3c49,
title = "Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase",
abstract = "Oxidant-mediated activation of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) plays a role in the development of endothelial dysfunction and the pathogenesis of various cardiovascular diseases. The aim of the current study was to investigate whether activation of PARP contributes to the development of endothelial dysfunction in the apolipoprotein E (ApoE) deficient mice. We tested whether PARP inhibition prevents the development of endothelial dysfunction and whether it restores function in vessels with established endothelial dysfunction. ApoE deficient mice were kept on high-fat diet for 12 weeks with and without INO-1001 treatment. Chronic treatment with the PARP inhibitor INO-100 reduced the degree of the endothelial dysfunction (the ability of the vessel to relax to acetylcholine) in the thoracic aortae of ApoE deficient mice. In addition, in vitro incubation of vessels from ApoE deficient mice with established endothelial dysfunction with the PARP inhibitor acutely improved the ability of the rings to relax to acetylcholine. We conclude that the early atherosclerotic functional alterations that develop in the endothelium of the ApoE deficient mice are, at least in part, reversible, and are dependent on the activation of the nuclear enzyme PARP in the endothelial cells.",
keywords = "Atherosclerosis, DNA, Endothelium, Oxidative stress",
author = "Rita Benk{\"o} and P{\'a}l Pacher and Anne Vaslin and M{\'a}rk Kollai and Csaba Szabo",
year = "2004",
month = "7",
day = "23",
doi = "10.1016/j.lfs.2004.04.007",
language = "English (US)",
volume = "75",
pages = "1255--1261",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase

AU - Benkö, Rita

AU - Pacher, Pál

AU - Vaslin, Anne

AU - Kollai, Márk

AU - Szabo, Csaba

PY - 2004/7/23

Y1 - 2004/7/23

N2 - Oxidant-mediated activation of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) plays a role in the development of endothelial dysfunction and the pathogenesis of various cardiovascular diseases. The aim of the current study was to investigate whether activation of PARP contributes to the development of endothelial dysfunction in the apolipoprotein E (ApoE) deficient mice. We tested whether PARP inhibition prevents the development of endothelial dysfunction and whether it restores function in vessels with established endothelial dysfunction. ApoE deficient mice were kept on high-fat diet for 12 weeks with and without INO-1001 treatment. Chronic treatment with the PARP inhibitor INO-100 reduced the degree of the endothelial dysfunction (the ability of the vessel to relax to acetylcholine) in the thoracic aortae of ApoE deficient mice. In addition, in vitro incubation of vessels from ApoE deficient mice with established endothelial dysfunction with the PARP inhibitor acutely improved the ability of the rings to relax to acetylcholine. We conclude that the early atherosclerotic functional alterations that develop in the endothelium of the ApoE deficient mice are, at least in part, reversible, and are dependent on the activation of the nuclear enzyme PARP in the endothelial cells.

AB - Oxidant-mediated activation of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) plays a role in the development of endothelial dysfunction and the pathogenesis of various cardiovascular diseases. The aim of the current study was to investigate whether activation of PARP contributes to the development of endothelial dysfunction in the apolipoprotein E (ApoE) deficient mice. We tested whether PARP inhibition prevents the development of endothelial dysfunction and whether it restores function in vessels with established endothelial dysfunction. ApoE deficient mice were kept on high-fat diet for 12 weeks with and without INO-1001 treatment. Chronic treatment with the PARP inhibitor INO-100 reduced the degree of the endothelial dysfunction (the ability of the vessel to relax to acetylcholine) in the thoracic aortae of ApoE deficient mice. In addition, in vitro incubation of vessels from ApoE deficient mice with established endothelial dysfunction with the PARP inhibitor acutely improved the ability of the rings to relax to acetylcholine. We conclude that the early atherosclerotic functional alterations that develop in the endothelium of the ApoE deficient mice are, at least in part, reversible, and are dependent on the activation of the nuclear enzyme PARP in the endothelial cells.

KW - Atherosclerosis

KW - DNA

KW - Endothelium

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=3042643028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042643028&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2004.04.007

DO - 10.1016/j.lfs.2004.04.007

M3 - Article

VL - 75

SP - 1255

EP - 1261

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 10

ER -